Diagnostic test for early detection of cognitive impairment and neurodegenerative disease risk. This biomarker-based test supports early intervention strategies for age-related cognitive disorders. The product aligns with research collaborations in epigenetic disease markers.
Manufactured by
China
BioChain (Beijing) Science & Technology Inc. is a pioneer in cancer early diagnosis and screening in China. The company specializes in developing NGS and PCR-based cancer gene methylation detection products, focusing on early cancer diagnosis reagent kits and large-scale laboratory screening platforms.
✦ Product-Specific Coverage
Based on AI-matched alternatives related to this product across Suplivia's medical sourcing network.
Generated for this product
AI-matched supplier coverage based on related product alternatives.
ADmit Therapeutics SL
Spain · 2 relevant products
Origin Biotechnology Co., Ltd.
Taiwan · 1 relevant product
GenSure Biotech Inc.
China · 1 relevant product
Fujirebio Diagnostics,Inc.
China · 2 relevant products
Singlera GENOMICS (SHANGHAI) Ltd.
China · 5 relevant products
Weihai Kangzhou Biotechnology Engineering Co.,Ltd
China · 2 relevant products
Rapid Technology LLC
Russia · 3 relevant products
Lansion Biotechnology Co., Ltd.
China · 2 relevant products
STRATEC/Diatron
Germany · 1 relevant product
Lumigenex (Suzhou) Co., Ltd
China · 1 relevant product
42 more relevant manufacturers available
Get free access to all relevant manufacturers for this product.
See all manufacturers →4 more sourcing countries available
Get free access to all sourcing countries identified for this product.
See all countries →See the full supplier coverage for this product
Get free access to all relevant manufacturers, sourcing countries, and product alternatives.
✓ Free for medical industry professionals.
from other manufacturers
from other manufacturers
12 of 81 closest product alternatives
ADmit Therapeutics SL · Spain
An early detection diagnostic test designed for clinical practice to identify Alzheimer's disease at preliminary stages. The test utilizes proprietary technology to support early diagnosis and patient management in clinical settings.
Origin Biotechnology Co., Ltd. · Taiwan
A diagnostic test for the assessment and diagnosis of dementia in elderly patients using molecular biomarkers.
GenSure Biotech Inc. · China
Diagnostic test kit for measurement of biomarkers associated with cerebrovascular disease and stroke risk. Facilitates assessment of neurological and cerebrovascular health status.
Fujirebio Diagnostics,Inc. · China
A cerebrospinal fluid detection test for Alzheimer's disease core biomarkers that provides enhanced sensitivity and more accurate results. This product targets the pathological hallmarks of Alzheimer's disease.
ADmit Therapeutics SL · Spain
A CE-marked in vitro diagnostic test that predicts progression from Mild Cognitive Impairment to Alzheimer's Disease Dementia using mitochondrial DNA epigenetic biomarkers. The test combines Next Generation Sequencing and Machine Learning analysis of blood biomarkers with ApoE genotype and age assessment to enable early detection and personalized medicine approaches.
Singlera GENOMICS (SHANGHAI) Ltd. · China
A specialized DNA methylation-based test for early detection and diagnosis of colorectal cancer. The test provides risk stratification and early screening capabilities for colorectal malignancies.
Weihai Kangzhou Biotechnology Engineering Co.,Ltd · China
A diagnostic test for detecting various diseases. The product is included in the company's clinical diagnostic testing offerings.
Rapid Technology LLC · Russia
Rapid diagnostic test for assessment of traumatic brain injury using key biomarkers.
Lansion Biotechnology Co., Ltd. · China
Dry fluorescence immunoassay test kit for Alzheimer disease-associated protein detection. Enables rapid neurodegenerative disease screening.
STRATEC/Diatron · Germany
Diagnostic test for identifying genetic disorders through molecular analysis of biological samples. The test can detect chromosomal abnormalities and inherited genetic conditions.
Singlera GENOMICS (SHANGHAI) Ltd. · China
A DNA methylation-based molecular diagnostic test designed for early detection and risk assessment across multiple cancer types. The test utilizes proprietary methylation technology to identify cancer signals in biological samples.
Lumigenex (Suzhou) Co., Ltd · China
Diagnostic test designed for chronic disease monitoring and management. Enables regular assessment of disease markers to guide ongoing patient treatment.
69 more product alternatives available
Create a free account to compare more product alternatives and supplier options.
© 2026 Suplivia · Home · Browse Products